Combined immunodeficiency with life-threatening EBV-associated lymphoproliferative disorder in patients lacking functional CD27

Haematologica

Volumn 98, Issue 3, 2013, Pages 473-478

  Salzer, Elisabeth ^a   Daschkey, Svenja ^b   Choo, Sharon ^c   Gombert, Michael ^b   Santos Valente, Elisangela ^a   Ginzel, Sebastian ^b   Schwendinger, Martina ^a   Haas, Oskar A ^d   Fritsch, Gerhard ^e   Pickl, Winfried F ^f   Förster Waldl, Elisabeth ^g   Borkhardt, Arndt ^b   Boztug, Kaan ^a,g   Bienemann, Kirsten ^b   Seidel, Markus G ^f,h  

^a ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^b Department of Orthopedic Surgery   (Germany)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

^d Medgenat GmbH   (Austria)

^e CHILDREN'S CANCER RESEARCH INSTITUTE   (Austria)

^f MEDICAL UNIVERSITY OF VIENNA   (Austria)

^g UNIV KLIN KINDER JUGENDHEILKUNDE   (Austria)

^h MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CD27 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IMMUNOGLOBULIN G; PREDNISOLONE; RITUXIMAB; STEROID; VINCRISTINE;

ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CHILD; CLINICAL ARTICLE; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; CYSTINE KNOT MOTIF; DISEASE ASSOCIATION; DRUG MEGADOSE; EPSTEIN BARR VIRUS; ERYTHROPHAGOCYTOSIS; EXOME; FEMALE; FLOW CYTOMETRY; GENOME ANALYSIS; HOMOZYGOSITY; HUMAN; IMMUNOGLOBULIN DEFICIENCY; IMMUNOPHENOTYPING; LYMPHOID CELL; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MALE; MULTIPLE CYCLE TREATMENT; NATURAL KILLER CELL; PRESCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; COMPLICATION; DEFICIENCY; EPSTEIN BARR VIRUS INFECTION; GENETICS; IMMUNOLOGY; INFANT; METABOLISM; PEDIGREE; PHENOTYPE; SEVERE COMBINED IMMUNODEFICIENCY; VIROLOGY;

ANTIGENS, CD27; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; INFANT; LYMPHOPROLIFERATIVE DISORDERS; MALE; PEDIGREE; PHENOTYPE; SEVERE COMBINED IMMUNODEFICIENCY;

EID: 84874537855     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2012.068791     Document Type: Article

References (34)

1. Bigler RD, Bushkin Y, Chiorazzi N. S152 (CD27). A modulating disulfide-linked T cell activation antigen. J Immunol. 1988; 141(1):21-8.
2. Camerini D, Walz G, Loenen WA, Borst J, Seed B. The T cell activation antigen CD27 is a member of the nerve growth factor/tumor necrosis factor receptor gene family. J Immunol. 1991;147(9):3165-9.
3. Gravestein LA, Amsen D, Boes M, Calvo CR, Kruisbeek AM, Borst J. The TNF receptor family member CD27 signals to Jun N-terminal kinase via Traf-2. Eur J Immunol. 1998;28(7):2208-16.
4. Hendriks J, Gravestein LA, Tesselaar K, van Lier RA, Schumacher TN, Borst J. CD27 is required for generation and long-term maintenance of T cell immunity. Nat Immunol. 2000;1(5):433-40.
5. Nolte MA, van Olffen RW, van Gisbergen KP, van Lier RA. Timing and tuning of CD27-CD70 interactions: the impact of signal strength in setting the balance between adaptive responses and immunopathology. Immunol Rev. 2009;229(1):216-31.
6. Klein U, Rajewsky K, Kuppers R. Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J Exp Med. 1998;188(9):1679-89.
7. Peperzak V, Xiao Y, Veraar EA, Borst J. CD27 sustains survival of CTLs in virusinfected nonlymphoid tissue in mice by inducing autocrine IL-2 production. J Clin Invest. 2010;120(1):168-78.
8. Dupre L, Andolfi G, Tangye SG, Clementi R, Locatelli F, Arico M, et al. SAP controls the cytolytic activity of CD8+ T cells against EBV-infected cells. Blood. 2005; 105(11):4383-9.
9. Huck K, Feyen O, Niehues T, Ruschendorf F, Hubner N, Laws HJ, et al. Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation. J Clin Invest. 2009;119(5):1350-8.
10. Williams H, Crawford DH. Epstein-Barr virus: the impact of scientific advances on clinical practice. Blood. 2006;107(3):862-9.
11. Filipovich AH. Hemophagocytic lympho-histiocytosis and other hemophagocytic disorders. Immunol Allergy Clin North Am. 2008;28(2):293-313.
12. Moosmann A, Bigalke I, Tischer J, Schirrmann L, Kasten J, Tippmer S, et al. Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells. Blood. 2010;115(14):2960-70.
13. Kuzmina Z, Greinix HT, Weigl R, Kormoczi U, Rottal A, Frantal S, et al. Significant differences in B-cell subpopulations characterize patients with chronic graft-versus-host disease-associated dysgammaglobulinemia. Blood. 2011;117(7): 2265-74.
14. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559-75.
15. Li H, Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics. 2010;26(5):589-95.
16. DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet. 2011;43(5):491-8.
17. Grant JR, Arantes AS, Liao X, Stothard P. In-depth annotation of SNPs arising from resequencing projects using NGS-SNP. Bioinformatics. 2011;27(16):2300-1.
18. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7(4):248-9.
19. Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4(7):1073-81.
20. Gonzalez-Perez A, Lopez-Bigas N. Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel. Am J Hum Genet. 2011;88(4):440-9.
21. Seidel MG. CD27: A new player in the field of common variable immunodeficiency and EBV-associated lymphoproliferative disorder? J Allergy Clin Immunol. 2012;129(4):1175.
22. van Montfrans JM, Hoepelman AI, Otto S, van Gijn M, van de Corput L, de Weger RA, et al. CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremia. J Allergy Clin Immunol. 2012;129(3):787-93.
23. Croft M. Costimulation of T cells by OX40, 4-1BB, and CD27. Cytokine Growth Factor Rev. 2003;14(3-4):265-73.
24. Pasquier B, Yin L, Fondaneche MC, Relouzat F, Bloch-Queyrat C, Lambert N, et al. Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product. J Exp Med. 2005;201(5):695-701.
25. Rigaud S, Fondaneche MC, Lambert N, Pasquier B, Mateo V, Soulas P, et al. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature. 2006;444(7115):110-4.
26. Xiao Y, Peperzak V, Keller AM, Borst J. CD27 instructs CD4 T cells to provide help for the memory CD8+ T cell response after protein immunization. J Immunol. 2008;181(2):1071-82.
27. Song DG, Ye Q, Poussin M, Harms GM, Figini M, Powell DJ Jr. CD27 costimulation augments the survival and antitumor activity of redirected human T cells in vivo. Blood. 2012;119(3):696-706.
28. DeBarros A, Chaves-Ferreira M, d'Orey F, Ribot JC, Silva-Santos B. CD70-CD27 inter-actions provide survival and proliferative signals that regulate T cell receptor-driven activation of human gammadelta peripheral blood lymphocytes. Eur J Immunol. 2011;41(1):195-201.
29. De Colvenaer V, Taveirne S, Delforche M, De Smedt M, Vandekerckhove B, Taghon T, et al. CD27-deficient mice show normal NK-cell differentiation but impaired function upon stimulation. Immunol Cell Biol. 2011;89(7):803-11.
30. Sugita K, Robertson MJ, Torimoto Y, Ritz J, Schlossman SF, Morimoto C. Participation of the CD27 antigen in the regulation of IL-2-activated human natural killer cells. J Immunol. 1992;149(4):1199-203.
31. Chapel H, Lucas M, Lee M, Bjorkander J, Webster D, Grimbacher B, et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood. 2008;112(2):277-86.
32. Alachkar H, Taubenheim N, Haeney MR, Durandy A, Arkwright PD. Memory switched B cell percentage and not serum immunoglobulin concentration is associated with clinical complications in children and adults with specific antibody deficiency and common variable immunodeficiency. Clin Immunol. 2006;120(3):310-8.
33. Cunningham-Rundles C. Common vari-able immunodeficiency. Curr Allergy Asthma Rep. 2001;1(5):421-9.
34. Wehr C, Kivioja T, Schmitt C, Ferry B, Witte T, Eren E, et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood. 2008;111(1):77-85.